Folic acid fortification: A double-edged sword

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 12, Issue 6, 2009, Pages 555-564

  Lucock, Mark ^a,b   Yates, Zoe ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; PLACEBO;

AUTISM; BREAST CANCER; CANCER RISK; CLINICAL TRIAL; COLON CANCER; DEGENERATIVE DISEASE; DEVELOPMENTAL DISORDER; DIET SUPPLEMENTATION; EPIGENETICS; FOLIC ACID BLOOD LEVEL; FUNCTIONAL FOOD; HEALTH CARE; HUMAN; INSULIN RESISTANCE; LIFE CYCLE; MENTAL DETERIORATION; PHENOTYPE; POPULATION EXPOSURE; REVIEW; VASCULAR DISEASE;

DIETARY SUPPLEMENTS; FOLIC ACID; FOOD, FORTIFIED; FUNCTIONAL FOOD; HUMANS; NEURAL TUBE DEFECTS; VITAMIN B COMPLEX;

EID: 70350135470     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e32833192bc     Document Type: Review

References (74)

1. MRC Vitamin Study Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338:131-137.
2. Lucock MD. Synergy of genes and nutrients: the case of homocysteine. Curr Opin Clin Nutr Metab Care 2006; 9:748-756.
3. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274:1049-1057.
4. Clarke R, Smith AD, Jobst KA, et al. Folate, vitamin B12 and serum total homocysteine levels in confirmed Alzheimer's disease. Arch Neurol 1998; 55:1449-1455.
5. Bottiglieri T. Homocysteine and folate metabolism in depression. Prog Neuro-psychopharmacol Biol Psychiatry 2005; 29:1103-1112.
6. Ulrich CM, Potter JD. Folate and cancer: timing is everything. JAMA 2007; 297:2408-2409.
7. Smith DA, Kim YI, Refsum H. Is folic acid good for everyone. Am J Clin Nutr 2008; 87:517-533.
8. Luebeck EG, Moolgavkar SH, Liu AY, et al. Does folic acid supplementation prevent or promote colorectal cancer? Results from model-based predictions. Cancer Epidemiol Biomarkers Prev 2008; 17:1360-1367.
9. Hirsch S, Sanchez H, Albala C, et al. Colon cancer in Chile before and after the start of the flour fortification program with folic acid. Eur J Gastroenterol Hepatol 2009 21 436-439
10. Bønaa KH, Njølstad I, Ueland PM, et al., for the NORVIT Trial Investigators. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006; 354:1578-1588.
11. Flynn MAT, Anderson WA, Burke SJ, et al. Folic acid food fortification: the Irish experience. Proc Nutr Soc 2008; 67:381-389.
12. Wright AJ, Dainty JR, Finglas PM. Folic acid metabolism in human subjects revisited: potential implications for proposed mandatory folic acid fortification in the UK. Br J Nutr 2007; 98:667-675.
13. Morris MS, Jacques PF, Rosenberg IH, Selhub J. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr 2007; 85:193-200.
14. Tangney CC, Tang Y, Evans DA, Morris MC. Biochemical indicators of vitamin B(12) and folate insufficiency and cognitive decline. Neurology 2009; 72:361-367.
15. Yajnik CS, Deshpande SS, Jackson AA, et al. Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study. Diabetologia 2008; 51:29-38.
16. Troen AM, Mitchell B, Sorensen B, et al. Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr 2006; 136:189-194.
17. Michels A, El Bakkali N, Bastiaenen CH, et al. Periconceptional folic acid use and the prevalence of positional plagiocephaly. J Craniofac Surg 2008; 19:37-39.
18. Haggarty P, McCallum H, McBain H, et al. Effect of B vitamins and genetics on success of in-vitro fertilisation: prospective cohort study. Lancet 2006; 367:1513-1519.
19. LucockM, Yates Z. Folic acid: Vitamin panacea or genetic time bomb. Nat Rev Genet 2005; 6:235-240.
20. Muñoz-Moran E, Dieguez-Lucena JL, Fernandez-Arcas N. Genetic selection and folate intake during pregnancy. Lancet 1998; 352:1120-1121.
21. Reyes-Engel A, Muñoz E, Gaitan MJ, et al. Implications on human fertility of the 677C>T and 1298A>C polymorphisms of the MTHFR gene: consequences of a possible genetic selection. Mol Hum Reprod 2002; 8: 952-957.
22. Lucock MD, Yates Z, Ng X, et al. Preliminary evidence for genetic selection of 677T-MTHFR by natural annual cycle of folate abundance. J Nutrigenet Nutrigenom 2008; 1:24-29.
23. Haggarty P, Campbell DM, Duthie S, et al. Folic acid use in pregnancy and embryo selection. BJOG 2008; 115:851-856.
24. Sohn KJ, Croxford R, Yates Z, et al. The effect of the methylenetetrahydro-folate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate. JNCI 2004; 96:134-144. (Pubitemid 38195904)
25. James SJ, Melnyk S, Jernigan S, et al. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet 2006; 141:947-956.
26. James SJ, Pogribna M, Pogribny IP, et al. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down's syndrome. Am J Clin Nutr 1999; 70:495-501.
27. Mills JL, Kirke PN, Molloy AM, et al. Methylenetetrahydrofolate reductase thermolabile variant and oral clefts. Am J Med Genet 2000; 92:79-80.
28. Muntjewerff JW, Hoogendoorn ML, Kahn RS, et al. Hyperhomocysteinemia, methylenetetrahydrofolate reductase 677TT genotype, and the risk for schizophrenia: a Dutch population based case-control study. Am J Med Genet B Neuropsychiatr Genet 2005; 135B:69-72.
29. Kempisty B, Bober A, ŁuczakM, et al. Distribution of 1298A>C polymorphism of methylenetetrahydrofolate reductase gene in patients with bipolar disorder and schizophrenia. Eur Psychiatry 2007; 22:39-43.
30. Durga J, Anteunis LJC, Schouten EG, et al. Association of folate with hearing is dependent on the 5,10-methylenetetrahydrofolate reductase 677C^T mutation. Neurobiol Aging 2006; 27:482-489.
31. Kara I, Sazci A, Ergul E, et al. Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res 2003; 111:84-90.
32. Lucock MD. Food fortification with folic acid. eBMJ; 1999. Electronic response 23 July. http://www.bmj.com/cgi/eletters/319/7202/92#EL1.
33. Lucock M. Is folic acid the ultimate functional food component for disease prevention? Br Med J 2004; 328:211-214.
34. Halsted CH. Perspectives on obesity and sweeteners, folic acid fortification and vitamin D requirements. Fam Pract 2008; 25:i44-49.
35. Sauer J, Mason JB, Choi SW. Too much folate: a risk factor for cancer and cardiovascular disease? Curr Opin Clin Nutr Metab Care 2009; 12:30-36.
36. Boulet SL, Yang Q, Mai C, et al. Trends in the postfortification prevalence of spina bifida and anencephaly in the United States. Birth Defects Res A Clin Mol Teratol 2008; 82:527-532.
37. Lucock MD, Wild J, Smithells R, Hartley R. In vivo characterisation of the absorption and biotransformation of pteroylglutamic acid in man: a model for future studies. Biochem Med Metab Biol 1989; 42:30-42.
38. Kelly P, McPartlin J,GogginsM, et al. Unmetabolised folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr 1997; 65:1790-1795.
39. Matthews RG, Haywood BJ. Inhibition of pig liver methylenetetrahydrofolate reductase by dihydrofolate: some mechanistic and regulatory implications. Biochemistry 1979; 18:4845-4851.
40. Cooney CA, Dave AA, Wolff GL. Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J Nutr 2002; 132:2393S-2400S.
41. Waterland RA, Jirtle RL. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 2003; 23:5293-5300.
42. Waterland RA, Dolinoy DC, Lin JR, et al. Maternal methyl supplements increase offspring DNA methylation at Axin Fused. Genesis 2006; 44: 401-406.
43. Cropley JE, Suter CM, Beckman KB, Martin DIK. Germ-line epigenetic modification of the murine Avy allele by nutritional supplementation. Proc Natl Acad Sci USA 2006; 103:17308-17312.
44. Cooney CA. Germ cells carry the epigenetic benefits of grandmother's diet. Proc Natl Acad Sci USA 2006; 103:17071-17072.
45. Lillycrop KA, Phillips ES, Jackson AA, et al. Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J Nutr 2005; 135:1382-1386.
46. Lucifero D, Chaillet JR, Trasler JM. Potential significance of genomic imprinting defects for reproduction and assisted reproductive technology. Hum Reprod Update 2004; 10:3-18.
47. Niemitz EL, Feinberg AP. Epigenetics and assisted reproductive technology: a call for investigation. Am J Hum Genet 2004; 74:599-609.
48. Isotalo PA, Wells GA, Donnelly JG. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations. Am J Hum Genet 2000; 67:986-990.
49. Adams M, LucockM, Stuart J, et al. Preliminary evidence for involvement of the folate gene polymorphism 19bp deletion-DHFR in occurrence of autism. Neurosci Lett 2007; 422:24-29.
50. Rogers JE. Has enhanced folate status during pregnancy altered natural selection and possibly Autism prevalence? A closer look at a possible link. Med Hypotheses 2008; 71:406-410.
51. Ramaekers VT, Blau N, Sequeira JM, et al. Folate receptor autoimmunity and cerebral folate deficiency in low functioning autism with neurological deficits. Neuropediatrics 2007; 38:276-281.
52. Ng X, Boyd L, Dufficy L, et al. Folate genes and risk for hypertension in an elderly population sample. J Nutrigenet Nutrigenom 2009; 2:1-8.
53. Lucock MD, Priestnall M, Daskalakis I, et al. Nonenzymatic degradation and salvage of dietary folate: physico-chemical factors likely to influence bioavail ability. Biochem Mol Med 1995; 55:43-53.
54. Ng X, Lucock MD, Veysey M. Physicochemical effect of pH and antioxidants on mono-and triglutamate forms of 5-methyltetrahydrofolate, and evaluation of vitamin stability in human gastric juice: implications for folate bioavailability. Food Chem 2008; 106:200-210.
55. Czeizel AE. Periconceptional folic acid containing multivitamin supplementation. Eur J Obstet Gynecol Reprod Biol 1998; 78:151-161.
56. Lindblad B, Zaman S, Malik A, et al. Folate, vitamin B12, and homocysteine levels in South Asian women with growth-retarded fetuses. Acta Obstet Gynecol Scand 2005; 84:1055-1061.
57. Wong WY, Thomas CMG, Merkus JMWM, et al. Male factor subfertility: possible causes and the impact of nutritional factors. Fertil Steril 2002; 77:491-498.
58. Goddijn-Wessel TA, Wouters MG, van de Molen EF, et al. Hyperhomocys-teinemia: a risk factor for placental abruption or infarction. Eur J Obstet Gynecol Reprod Biol 1996; 66:23-29.
59. Wen SW, Chen XK, Rodger M, et al. Folic acid supplementation in early second trimester and the risk of preeclampsia. Am J Obstet Gynecol 2008; 198:45.e1-45.e7.
60. Nelen WL, Blom HJ, Steegers EA, et al. Homocysteine and folate levels as risk factors for recurrent early pregnancy loss. Obstet Gynecol 2000; 95:519-524.
61. Hook EB, Czeizel AE. Can terathanasia explain the protective effect of folic-acid supplementation on birth defects? Lancet 1997; 350:513-515.
62. Quadri P, Fragiacomo C, Pezzati R, et al. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr 2004; 80:114-122.
63. Zhao R, Gao F, Goldman ID. Marked suppression of the activity of some, but not all, antifolate compounds by augmentation of folate cofactor pools within tumor cells. Biochem Pharmacol 2001; 61:857-865.
64. Chattopadhyay S, Tamari R, Min SH, et al. Commentary: a case for minimizing folate supplementation in clinical regimens with pemetrexed based on the marked sensitivity of the drug to folate availability. Oncologist 2007; 12:808-815.
65. Stolzenberg-Solomon RZ, Chang SC, Leitzmann MF, et al. Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr 2006; 83:895-904.
66. Piyathilake CJ, Celedonio JE, Macaluso M, et al. Mandatory fortification with folic acid in the United States is associated with increased expression of DNA methyltransferase-1 in the cervix. Nutrition 2008; 24:94-99.
67. Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007; 297:2351-2359.
68. Janne PA, Mayer RJ. Chemoprevention of colorectal cancer. N Eng J Med 2000; 342:1960-1968.
69. Godfrey PS, Toone BK, Carney MW, et al. Enhancement of recovery from psychiatric illness by methylfolate. Lancet 1990; 336:392-395.
70. Larsson SC, Håkansson N, Giovannucci E, Wolk A. Folate intake and pancreatic cancer incidence: a prospective study of Swedish women and men. JNCI 2006; 98:407-413.
71. Johansson M, Appleby PN, Allen NE, et al. Circulating concentrations of folate and vitamin B12 in relation to prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition study. Cancer Epidemiol Biomarkers Prev 2008; 17:279-285.
72. Salim A, Tan E, Ilchyshyn A, Berth-Jones J. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial. Br J Dermatol 2006; 154:1169-1174.
73. Khanna D, Park GS, Paulus HE, et al. Reduction of the efficacy of metho-trexate by the use of folic acid: post hoc analysis from two randomized controlled studies. Arthritis Rheum 2005; 52:3030-3038.
74. Wang X, Qin X, Demirtas H, et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 2007; 369:1876-1882.